Walleye Capital’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-800,000
| Closed | -$28M | – | 3139 |
|
|
2024
Q1 | $28M | Buy |
+800,000
| New | +$28M | 0.05% | 53 |
|
|
2023
Q4 | – | Sell |
-70,850
| Closed | -$1.3M | – | 3317 |
|
|
2023
Q3 | $1.3M | Buy |
70,850
+37,744
| +114% | +$693K | ﹤0.01% | 801 |
|
|
2023
Q2 | $859K | Sell |
33,106
-119,746
| -78% | -$3.11M | ﹤0.01% | 796 |
|
|
2023
Q1 | $2.88M | Sell |
152,852
-54,130
| -26% | -$1.02M | 0.04% | 418 |
|
|
2022
Q4 | $5.1M | Buy |
206,982
+97,166
| +88% | +$2.39M | 0.09% | 250 |
|
|
2022
Q3 | $1.97M | Buy |
109,816
+41,678
| +61% | +$748K | 0.04% | 453 |
|
|
2022
Q2 | $773K | Sell |
68,138
-42,394
| -38% | -$481K | 0.02% | 763 |
|
|
2022
Q1 | $2.46M | Buy |
110,532
+54,999
| +99% | +$1.23M | 0.07% | 298 |
|
|
2021
Q4 | $2.43M | Buy |
+55,533
| New | +$2.43M | 0.08% | 280 |
|